The myocardial viability substudy from the STICH trial has reaffirmed the 10-year survival benefit of CABG surgery in patients with left ventricular dysfunction, but whether myocardial viability must be present for the long-term benefits of revascularization to be realized remains inconclusive.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Braunwald, E. & Rutherford, J. D. Reversible ischemic left ventricular dysfunction: evidence for the “hibernating myocardium”. J. Am. Coll. Cardiol. 8, 1467–1470 (1986).
Allman, K. C. et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J. Am. Coll. Cardiol. 39, 1151–1158 (2002).
Camici, P. G., Prasad, S. K. & Rimoldi, O. E. Stunning, hibernation, and assessment of myocardial viability. Circulation 117, 103–114 (2008).
Orlandini, A. et al. Myocardial viability for decision-making concerning revascularization in patients with left ventricular dysfunction and coronary artery disease: a meta-analysis of non-randomized and randomized studies. Int. J. Cardiol. 182, 494–499 (2015).
Panza, J. A. et al. Myocardial viability and long-term outcomes in ischemic cardiomyopathy. N. Engl. J. Med. 381, 739–748 (2019).
Beanlands, R. S. et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J. Am. Coll. Cardiol. 50, 2002–2012 (2007).
Cleland, J. G. et al. The Heart Failure Revascularisation Trial (HEART). Eur. J. Heart Fail. 13, 227–233 (2011).
Alosh, M. et al. Tutorial on statistical considerations on subgroup analysis in confirmatory clinical trials. Stat. Med. 36, 1334–1360 (2017).
Patel, H. et al. Myocardial viability-state of the art: is it still relevant and how to best assess it with imaging? Trends Cardiovasc. Med. 28, 24–37 (2018).
Page, B. J. et al. Revascularization of chronic hibernating myocardium stimulates myocyte proliferation and partially reverses chronic adaptations to ischemia. J. Am. Coll. Cardiol. 65, 684–697 (2015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests
Rights and permissions
About this article
Cite this article
Redfors, B., Stone, G.W. Myocardial viability and CABG surgery: a Bayesian appraisal of STICH. Nat Rev Cardiol 16, 702–703 (2019). https://doi.org/10.1038/s41569-019-0292-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-019-0292-0